KalVista Pharmaceuticals, Inc. (KALV) Insider Trading
Over the last 6 months, 67 institutions increased and 47 reduced their position (13F).
Insider Activity
Sentiment
50/100
Buys (3m)
0
Sells (3m)
0
Net (3m)
$0
Insider trades by month Buys Sells
Nov
Dec
Feb
Mar
Apr
May
Context3-month price +59.4%Institutions reducing (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 29, 2026 | Yea Christopherofficer: CHIEF DEVELOPMENT OFFICER | Sell | 33,800 | $26.78 |
| May 29, 2026 | Yea Christopherofficer: CHIEF DEVELOPMENT OFFICER | Option | 33,800 | $7.07 |
| May 27, 2026 | Yea Christopherofficer: CHIEF DEVELOPMENT OFFICER | Option | 3,125 | — |
| May 27, 2026 | Sweeny Nicoleofficer: Chief Commercial Officer | Option | 5,000 | — |
| May 27, 2026 | Yea Christopherofficer: CHIEF DEVELOPMENT OFFICER | Sell | 1,966 | $26.78 |
| May 27, 2026 | Sweeny Nicoleofficer: Chief Commercial Officer | Sell | 1,489 | $26.78 |
| May 27, 2026 | Audhya Paul K.officer: CHIEF MEDICAL OFFICER | Option | 5,000 | — |
| May 27, 2026 | Audhya Paul K.officer: CHIEF MEDICAL OFFICER | Sell | 2,239 | $26.78 |
| May 26, 2026 | Piekos Brianofficer: Chief Financial Officer | Sell | 1,489 | $26.78 |
| May 26, 2026 | Audhya Paul K.officer: CHIEF MEDICAL OFFICER | Sell | 2,685 | $26.78 |
| May 26, 2026 | Audhya Paul K.officer: CHIEF MEDICAL OFFICER | Option | 6,250 | — |
| May 26, 2026 | Yea Christopherofficer: CHIEF DEVELOPMENT OFFICER | Sell | 2,358 | $26.78 |
| May 26, 2026 | Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICER | Option | 23,250 | — |
| May 26, 2026 | Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICER | Sell | 10,926 | $26.78 |
| May 26, 2026 | Yea Christopherofficer: CHIEF DEVELOPMENT OFFICER | Option | 3,750 | — |
| May 26, 2026 | Sweeny Nicoleofficer: Chief Commercial Officer | Sell | 1,861 | $26.78 |
| May 26, 2026 | Piekos Brianofficer: Chief Financial Officer | Option | 5,000 | — |
| May 26, 2026 | Sweeny Nicoleofficer: Chief Commercial Officer | Option | 6,250 | — |
| May 19, 2026 | Audhya Paul K.officer: CHIEF MEDICAL OFFICER | Option | 2,419 | — |
| May 19, 2026 | Yea Christopherofficer: CHIEF DEVELOPMENT OFFICER | Sell | 1,108 | $26.76 |
| May 19, 2026 | Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICER | Option | 2,419 | — |
| May 19, 2026 | Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICER | Sell | 1,129 | $26.76 |
| May 19, 2026 | Yea Christopherofficer: CHIEF DEVELOPMENT OFFICER | Option | 1,774 | — |
| May 19, 2026 | Audhya Paul K.officer: CHIEF MEDICAL OFFICER | Sell | 1,032 | $26.76 |
| May 13, 2026 | Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICER | Option | 7,120 | — |
| May 13, 2026 | Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICER | Sell | 3,322 | $26.71 |
| Apr 20, 2026 | Piekos Brianofficer: Chief Financial Officer | Option | 6,250 | — |
| Apr 20, 2026 | Sweeny Nicoleofficer: Chief Commercial Officer | Sell | 1,862 | $20.22 |
| Apr 20, 2026 | Audhya Paul K.officer: CHIEF MEDICAL OFFICER | Sell | 2,686 | $20.22 |
| Apr 20, 2026 | Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICER | Option | 20,312 | — |
Source: KALV SEC Form 4 filings, latest May 29, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their KALV positions over the last 6 months (SEC Form 13F).
Increased
67
New positions
41
Reduced
47
Sold out
182
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| VR ADVISER, LLC | Reduced | 6.5M | May 15, 2026 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Reduced | 5.0M | May 15, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Unchanged | 4.8M | May 15, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Unchanged | 4.6M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 3.8M | May 13, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | Increased | 2.9M | May 14, 2026 |
| CAPITAL WORLD INVESTORS | Unchanged | 2.8M | May 13, 2026 |
| CAPTION MANAGEMENT, LLC | Increased | 2.4M | May 15, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Reduced | 2.1M | May 15, 2026 |
| STATE STREET CORP | Increased | 2.0M | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 1.9M | May 15, 2026 |
| VESTAL POINT CAPITAL, LP | Reduced | 1.9M | May 15, 2026 |
| PARKMAN HEALTHCARE PARTNERS LLC | Increased | 1.8M | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1.8M | May 15, 2026 |
| KYNAM CAPITAL MANAGEMENT, LP | Increased | 1.8M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.